+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
BioCryst Pharmaceuticals Inc - logo

BioCryst Pharmaceuticals is a biotechnology company that designs and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. BioCryst's core development programs include BCX7353 and additional 2nd generation oral inhibitors of plasma kallikrein for hereditary angioedema; and BCX4430 (GALIDESIVIR), a broad spectrum antiviral for hemorrhagic fevers. The company was founded in 1986 and is headquartered in Durham, North Carolina.

Ebola Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, and Product Type - Product Thumbnail Image

Ebola Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, and Product Type

  • Report
  • January 2024
  • 94 Pages
  • Global
From
Influenza Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Influenza Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • February 2024
  • 102 Pages
  • Global
From
Coronavirus (COVID-19) Current Therapy Global Market Report 2023 - Product Thumbnail Image

Coronavirus (COVID-19) Current Therapy Global Market Report 2023

  • Report
  • February 2023
  • 250 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2020-2025 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2020-2025

  • Report
  • September 2025
  • 1000 Pages
  • Global
From
Paroxysmal Nocturnal Hemoglobinuria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Paroxysmal Nocturnal Hemoglobinuria Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 131 Pages
  • Global
From
Ebola Drugs and Vaccines - Global Strategic Business Report - Product Thumbnail Image

Ebola Drugs and Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 485 Pages
  • Global
From
Ebola Virus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Ebola Virus Vaccines - Global Strategic Business Report

  • Report
  • September 2025
  • 336 Pages
  • Global
From
Gout Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Gout Disease Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 473 Pages
  • Global
From
Fertility Drugs Market Report 2025 - Product Thumbnail Image

Fertility Drugs Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Myeloid Cells Targeting Therapeutics Market by Type of Molecule (Small Molecule and Biologics), Therapeutic Area (Oncological Disorders and Rare Disorders), Route of Administration (Intravenous and Oral) and Geography (North America, Europe and Asia Pacific), 2021-2035 - Product Thumbnail Image

Myeloid Cells Targeting Therapeutics Market by Type of Molecule (Small Molecule and Biologics), Therapeutic Area (Oncological Disorders and Rare Disorders), Route of Administration (Intravenous and Oral) and Geography (North America, Europe and Asia Pacific), 2021-2035

  • Report
  • January 2022
  • 212 Pages
  • Global
From
Oral Complement Inhibitors Market - Global Forecast 2025-2030 - Product Thumbnail Image

Oral Complement Inhibitors Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 192 Pages
  • Global
From
Next Generation Complement Therapeutics Market: Distribution by Target Disease Indication, Therapeutic Area, Type of Molecule, Target Pathway, Type of Therapy, Route of Administration, Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Next Generation Complement Therapeutics Market: Distribution by Target Disease Indication, Therapeutic Area, Type of Molecule, Target Pathway, Type of Therapy, Route of Administration, Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • February 2022
  • 131 Pages
  • Global
From
Paroxysmal Nocturnal Hemoglobinuria (PNH) Market Report 2025 - Product Thumbnail Image

Paroxysmal Nocturnal Hemoglobinuria (PNH) Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Recombinant Uricase Market - Global Forecast 2025-2030 - Product Thumbnail Image

Recombinant Uricase Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 194 Pages
  • Global
From
Paroxysmal Nocturnal Haemoglobinuria - Pipeline Insight, 2025 - Product Thumbnail Image

Paroxysmal Nocturnal Haemoglobinuria - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Plasma Protease C1 Inhibitor Market 2024-2028 - Product Thumbnail Image

Plasma Protease C1 Inhibitor Market 2024-2028

  • Report
  • January 2024
  • 166 Pages
  • Global
From
Kallikrein Inhibitors Market - Global Forecast 2025-2030 - Product Thumbnail Image

Kallikrein Inhibitors Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
Autoimmune Treatment Market Report 2025 - Product Thumbnail Image

Autoimmune Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
ACVR1 Protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

ACVR1 Protein Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures - Product Thumbnail Image

Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures

  • Report
  • May 2019
  • 385 Pages
  • Global
From
Loading Indicator